Pfizer (PFE) will buy cancer specialist Seagen (SGEN) for roughly $43 billion as Sanofi (SNY) takes over Provention Bio (PRVB) for about $2.9 billion, the companies announced Monday. In response, SGEN...
Pfizer (PFE) will buy cancer specialist Seagen (SGEN) for roughly $43 billion as Sanofi (SNY) takes over Provention Bio (PRVB) for about $2.9 billion, the companies announced Monday. In response, SGEN...